HIV and HTLV-1 coinfection: The need to initiate antiretroviral therapy

Journal of the International Association of Providers of AIDS Care

Volumn 12, Issue 6, 2013, Pages 373-374

  Ticona, Eduardo ^a,b   Huaman, Moises A ^c   Yanque, Omar ^a,b   Zunt, Joseph R ^d  

^a HOSPITAL NACIONAL DOS DE MAYO   (Peru)

^b UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CHEMOKINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; DEMENTIA; HEPATITIS B VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1 INFECTION; IMMUNE STATUS; LETTER; MIXED INFECTION; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUBERCULOSIS; VIRUS INFECTION;

EID: 84887867894     PISSN: 23259574     EISSN: 23259582     Source Type: Journal    
DOI: 10.1177/2325957413500988     Document Type: Letter

References (14)

1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, February 2013. http://www.aidsinfo.nih. gov/guidelines. Accessed April 19, 2013.
2. Zane L, Sibon D, Mortreux F, Wattel E.. Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype. Front Biosci. 2009 ; 14: 3935-3941
3. Brites C, Sampalo J, Oliveira A. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev. 2009 ; 11 (1). 8-16
4. Regis C, Oliveira A, Brites C. Onset of opportunistic infections in patients co-infected by HTLV-1 and HIV-1, with high CD4+ cells count. Braz J Infect Dis. 2009 ; 13 (4). 311-313
5. Bahia F, Novais V, Evans J, et al. The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus. J Acquir Immune Defic Syndr. 2011 ; 57 (suppl 3). S202 - S207
6. Casoli C, Pilotti E, Bertazzoni U. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. AIDS Rev. 2007 ; 9 (3). 140-149
7. Gudo ES, Bhatt NB, Bila DR, et al. Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?. BMC Infect Dis. 2009 ; 9: 211
8. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med. 1997 ; 185 (4). 621-628
9. Abrahao MH, Lima RG, Netto E, Brites C. Short communication: human lymphotropic virus type 1 coinfection modulates the synthesis of cytokines by peripheral blood mononuclear cells from HIV type 1-infected individuals. AIDS Res Hum Retroviruses. 2012 ; 28 (8). 806-808
10. Marinho J, Galvao-Castro B, Rodrigues LC, Barreto ML. Increased risk of tuberculosis with human T-lymphotropic virus-1 infection: a case-control study. J Acquir Immune Defic Syndr. 2005 ; 40 (5). 625-628
11. Pedral-Sampaio DB, Martins Netto E, Pedrosa C, Brites C, Duarte M, Harrington W. Co-Infection of tuberculosis and HIV/HTLV retroviruses: frequency and prognosis among patients admitted in a Brazilian hospital. Braz J Infect Dis. 1997 ; 1 (1). 31-35
12. Norrgren HR, Bamba S, Larsen O, et al. Increased prevalence of HTLV-1 in patients with pulmonary tuberculosis coinfected with HIV, but not in HIV-negative patients with tuberculosis. J Acquir Immune Defic Syndr. 2008 ; 48 (5). 607-610
13. Demontis MA, Hilburn S, Taylor GP. Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases. AIDS Res Hum Retroviruses. 2013 ; 29 (2). 359-364
14. Beilke MA.. Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research. AIDS Res Hum Retroviruses. 2012 ; 28 (2). 139-147